Taiwan · Delayed Price · Currency is TWD Formosa Pharmaceuticals Statistics
Total Valuation
TPE:6838 has a market cap or net worth of TWD 3.13 billion. The enterprise value is 2.15 billion.
| Market Cap | 3.13B |
| Enterprise Value | 2.15B |
Important Dates
The next estimated earnings date is Wednesday, November 18, 2026.
| Earnings Date | Nov 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPE:6838 has 150.98 million shares outstanding. The number of shares has increased by 3.00% in one year.
| Current Share Class | 150.98M |
| Shares Outstanding | 150.98M |
| Shares Change (YoY) | +3.00% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 9.09% |
| Float | 83.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 60.63 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 3.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 41.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.55, with a Debt / Equity ratio of 0.02.
| Current Ratio | 27.55 |
| Quick Ratio | 22.35 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -408.05 |
Financial Efficiency
Return on equity (ROE) is -16.81% and return on invested capital (ROIC) is -9.08%.
| Return on Equity (ROE) | -16.81% |
| Return on Assets (ROA) | -6.48% |
| Return on Invested Capital (ROIC) | -9.08% |
| Return on Capital Employed (ROCE) | -11.33% |
| Weighted Average Cost of Capital (WACC) | 7.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | 5.44 |
Taxes
In the past 12 months, TPE:6838 has paid 2.26 million in taxes.
| Income Tax | 2.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.99% in the last 52 weeks. The beta is 0.64, so TPE:6838's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -23.99% |
| 50-Day Moving Average | 24.09 |
| 200-Day Moving Average | 25.64 |
| Relative Strength Index (RSI) | 27.91 |
| Average Volume (20 Days) | 133,983 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:6838 had revenue of TWD 51.67 million and -234.00 million in losses. Loss per share was -1.53.
| Revenue | 51.67M |
| Gross Profit | 27.98M |
| Operating Income | -205.66M |
| Pretax Income | -231.70M |
| Net Income | -234.00M |
| EBITDA | -160.03M |
| EBIT | -205.66M |
| Loss Per Share | -1.53 |
Balance Sheet
The company has 1.01 billion in cash and 23.69 million in debt, with a net cash position of 985.70 million or 6.53 per share.
| Cash & Cash Equivalents | 1.01B |
| Total Debt | 23.69M |
| Net Cash | 985.70M |
| Net Cash Per Share | 6.53 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 8.39 |
| Working Capital | 1.29B |
Cash Flow
In the last 12 months, operating cash flow was -469.51 million and capital expenditures -7.18 million, giving a free cash flow of -476.69 million.
| Operating Cash Flow | -469.51M |
| Capital Expenditures | -7.18M |
| Depreciation & Amortization | 45.62M |
| Net Borrowing | -6.70M |
| Free Cash Flow | -476.69M |
| FCF Per Share | -3.16 |
Margins
| Gross Margin | 54.15% |
| Operating Margin | -397.99% |
| Pretax Margin | -448.39% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPE:6838 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.00% |
| Shareholder Yield | -3.00% |
| Earnings Yield | -7.36% |
| FCF Yield | -15.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |